glp 1 data Rx Trends: Real-World on GLP-1s for Weight Loss The GLP-1 trend: What the

Do not break, crush, or chew the tablet

Data presented are for the efficacy estimand unless otherwise noted CVD cardiovascular disease, HbA1c glycated hemoglobin, MACE major adverse cardiac events, MMO morbidity mortality obesity, T2D type 2 diabetes a MACE-5 comprised all-cause death, nonfatal myocardial infarction, nonfatal stroke, unstable angina requiring hospitalization or revascularization, and coronary revascularization Table 3

Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1-mediated thermogenesis in white and brown adipose tissue

Naunyn Schmiedebergs Arch Pharmacol (2009) 379:3858

Best results are seen with consistent use for at least three to six months combined with healthy lifestyle habits including nutritious eating, physical activity, and adequate rest

Tirzepatide acts through both GIP and GLP-1 receptor pathways